tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Nxera Pharma Achieves Key Milestone in AbbVie Collaboration
Company AnnouncementsNxera Pharma Achieves Key Milestone in AbbVie Collaboration
26d ago
Nxera Pharma Advances Cancer Immunotherapy to Phase 2a Trial
PremiumCompany Announcements
Nxera Pharma Advances Cancer Immunotherapy to Phase 2a Trial
1M ago
Nxera Pharma Reports Revenue Growth Amid Net Loss
PremiumCompany Announcements
Nxera Pharma Reports Revenue Growth Amid Net Loss
3M ago
Nxera Pharma Reports Strong First Half 2025 Results and Strategic Advances
PremiumCompany Announcements
Nxera Pharma Reports Strong First Half 2025 Results and Strategic Advances
3M ago
Nxera Pharma Unveils New Obesity Treatment Pipeline
PremiumCompany Announcements
Nxera Pharma Unveils New Obesity Treatment Pipeline
3M ago
Nxera Pharma Secures $4.8 Million Milestone Payment from Centessa
PremiumCompany AnnouncementsNxera Pharma Secures $4.8 Million Milestone Payment from Centessa
4M ago
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
Premium
Company Announcements
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
5M ago
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
Premium
Company Announcements
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
5M ago
Nxera Pharma Reports Revenue Growth Amidst Losses
PremiumCompany Announcements
Nxera Pharma Reports Revenue Growth Amidst Losses
6M ago
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
PremiumCompany Announcements
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
6M ago
Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
PremiumCompany Announcements
Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
6M ago
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
6M ago
Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
PremiumCompany AnnouncementsNxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
7M ago
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
Premium
Company Announcements
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
8M ago
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
Premium
Company Announcements
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
8M ago
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
PremiumCompany Announcements
Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
8M ago
Nxera Pharma Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Nxera Pharma Reports Strong Revenue Growth in 2024
8M ago
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
PremiumCompany Announcements
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
8M ago
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
PremiumCompany Announcements
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
8M ago
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
PremiumCompany AnnouncementsNxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
8M ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
Premium
Company Announcements
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >